Clinical Trials Logo
  1. Home
  2. Renal Anemia
  3. NCT05864261

Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers

Renal Anemia Clinical Trial

Official title:
A Randomized, Blinding, Single-dose, Positive-drug Parallel Control Study to Compare the Pharmacokinetics Following Administration of JT1801 and Darbepoetin Alfa Injection (NESP®) in Chinese Healthy Adult Volunteers

Clinical Trial Summary

The purpose of this study is to compare the similarity of major pharmacokinetic parameters after a single intravenous administration of JT1801 and NESP® in chinese healthy male volunteers. And to evaluate the safety, immunogenicity and pharmacodynamic characteristics of JT1801 and NESP® in chinese healthy male volunteers

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05864261
Study type Interventional
Source Peking University People's Hospital
Contact
Status Completed
Phase Phase 4
Start date May 15, 2023
Completion date August 28, 2023
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04925661 - HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia Phase 1
Active, not recruiting NCT03388385 - Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD Phase 4
Completed NCT05035641 - A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients Phase 2
Completed NCT02299661 - Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease Phase 1
Active, not recruiting NCT05265325 - A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis Phase 2
Active, not recruiting NCT05085275 - Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease Phase 3
Completed NCT02708914 - Study to Compare the Safety and Efficacy of UB-851 and Eprex® Phase 3
Completed NCT02041208 - Variability of Hemoglobin Levels After Kidney Transplantation N/A
Not yet recruiting NCT04775615 - Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects. Phase 1
Completed NCT00298441 - Efficacy of Intravenous Iron Administration in Hemodialysis Patients Phase 4
Active, not recruiting NCT04408820 - Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia
Completed NCT01543477 - Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia
Completed NCT05951192 - A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease Phase 4
Completed NCT04454879 - Different Doses of Roxadustat Treatment for Anemia in Peritoneal Dialysis Patients Phase 4
Recruiting NCT04360902 - Assessment of an Anemia Model Predictive Controller for Anemia Management in Hemodialysis Patients N/A
Not yet recruiting NCT03480178 - Renal Anemia Refractory to Erythropoietin
Completed NCT01306409 - Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA) Phase 4
Completed NCT00322413 - Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial Phase 3
Recruiting NCT05970172 - A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease Phase 3
Completed NCT02947438 - Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study) Phase 3